Schriml, Lynn
The ISO/TR 10993-22 document clearly states: The manufacturing and use of nanomaterials are due to their specific properties, which may be related to the reduction in size accompanied by surface roughness. Therefore, the evaluation of nanomaterials cannot rely solely on traditional material testing methods
**The FDA does not review or approve any compounded medications for safety or effectiveness
Cellular viability Optimization of Sp concentration and its cytotoxicity parameters were established by treating of 1.5 10 5 HeLa or 1.2 10 5 SHSY-5Y cells with serial concentrations of the Sp (100 M1 mM) for 15 min or conducting a time-course (5 min48 h) using 250 M Sp, followed by MTT assay as per standard protocol (Thermo Fisher Scientific)
These are framed as may-support outcomes, not guarantees, and they depend on the individual
Vavilin VA, Makarova SI, Lyakhovich VV, Gavalov SM